I imagine DTG/RPV would be out because of the dependence on PPI therapy. Injectable LA CAB/RPV might be an option, but IMO, I ...
William, Dr. Gallant brought up the point I was going to make which is that ETR is an inducer of CYP3A4 and so is not recommended ...
Will, You sent me a message with a question, but I couldn't figure out how to respond. You asked about Juluca in HTE patients. ...
Hi William, Wow. Tough case. If the goal is to remove the boosting agent and to get to the lowest pill burden, how about ...
William, A complicated case indeed! Unfortunately, you're not supposed to combine ETR with LEN due to ETR's induction of CYP3A4 ...
I took over the care for a very treatment experienced patient (HIV for 30+ years, multiple failures prior to INSTI) with a high ...
Hi Samuel, I keep patient's on a 3-active medication regimen vs. two-active especially if they are suppressed <50 copies and ...
Hi Emily. You're right, checking the HepBcAb differentiates between people who have been infected with Hep B and people who ...
Good morning, I'm seeking contact information for a neurologist in the DMV area who is familiar with PLWH. I have a client ...
My routine visits are 15 min. For new diagnosis those are same day started and just get added into my schedule or the NP's schedule. ...
Either the content you're seeking doesn't exist or it requires proper authentication before viewing.
Academy National Office1600 K St NW | Suite 350Washington, D.C. 20006
Phone: 202-659-0699Fax: 202-659-0976
JoinBenefitsLearn More
About UsTerms of UsePrivacy Policy Policy on Managing Conflicts of Interest